{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:37:08Z","timestamp":1789141028700,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10620-024-08514-6","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T15:02:33Z","timestamp":1720105353000},"page":"2796-2803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"69","author":[{"given":"Alexander","family":"Abadir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Troia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyder","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spurthi","family":"Tarugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Sairam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Minchenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna H.","family":"Owings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Carlyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby R.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pegah","family":"Hosseini-Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Galeas-Pena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Frasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papamichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Cheifetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,4]]},"reference":[{"key":"8514_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.cgh.2018.02.027","volume":"16","author":"B Kerur","year":"2018","unstructured":"Kerur B, Machan JT, Shapiro JM et al. Biologics delay progression of crohn\u2019s disease, but not early surgery, in children. Clin Gastroenterol Hepatol 2018;16:1467\u20131473.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8514_CR2","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.2147\/CLEP.S178056","volume":"10","author":"EI Benchimol","year":"2018","unstructured":"Benchimol EI, Kuenzig ME, Bernstein CN et al. Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study. Clin Epidemiol 2018;10:1613\u20131626.","journal-title":"Clin Epidemiol"},{"key":"8514_CR3","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.gastro.2020.08.064","volume":"160","author":"EL Barnes","year":"2021","unstructured":"Barnes EL, Loftus EV, Kappelman MD. Effects of race and ethnicity on diagnosis and management of inflammatory bowel diseases. Gastroenterology 2021;160:677\u2013689.","journal-title":"Gastroenterology"},{"key":"8514_CR4","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/ajg.2013.192","volume":"108","author":"KK Lin","year":"2013","unstructured":"Lin KK, Sewell JL. The effects of race and socioeconomic status on immunomodulator and anti-tumor necrosis factor use among ambulatory patients with inflammatory bowel disease in the United States. Am J Gastroenterol 2013;108:1824\u20131830.","journal-title":"Am J Gastroenterol"},{"key":"8514_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.cgh.2017.05.047","volume":"16","author":"HY Shi","year":"2018","unstructured":"Shi HY, Levy AN, Trivedi HD et al. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clin Gastroenterol Hepatol 2018;16:190\u2013197.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8514_CR6","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/ajg.2010.202","volume":"105","author":"GC Nguyen","year":"2010","unstructured":"Nguyen GC, LaVeist TA, Harris ML et al. Racial disparities in utilization of specialist care and medications in inflammatory bowel disease. Am J Gastroenterol 2010;105:2202\u20132208.","journal-title":"Am J Gastroenterol"},{"key":"8514_CR7","doi-asserted-by":"crossref","unstructured":"Dos Santos Marques IC, Theiss LM, Baker SJ, et al. Low health literacy exists in the inflammatory bowel disease (IBD) population and is disproportionately prevalent in older African Americans. Crohns Colitis 360 2020;2:otaa076.","DOI":"10.1093\/crocol\/otaa076"},{"key":"8514_CR8","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1016\/j.cgh.2022.03.011","volume":"20","author":"A Anyane-Yeboa","year":"2022","unstructured":"Anyane-Yeboa A, Quezada S, Rubin DT et al. The impact of the social determinants of health on disparities in inflammatory bowel disease. Clin Gastroenterol Hepatol 2022;20:2427\u20132434.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8514_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izz104","volume":"26","author":"KT Park","year":"2020","unstructured":"Park KT et al. The Cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation. Inflamm Bowel Dis 2020;26:1\u201310.","journal-title":"Inflamm Bowel Dis"},{"key":"8514_CR10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1093\/ibd\/izz013","volume":"25","author":"S Bhat","year":"2019","unstructured":"Bhat S, Zahorian T, Robert R et al. Advocating for patients with inflammatory bowel disease: how to navigate the prior authorization process. Inflamm Bowel Dis 2019;25:1621\u20131628.","journal-title":"Inflamm Bowel Dis"},{"key":"8514_CR11","doi-asserted-by":"crossref","unstructured":"Weinstein JN, Geller A, Negussie Y, et al. Communities in action: pathways to health equity. Communities in action: pathways to health equity. Washington (DC): National Academies Press (US); 2017:1\u2013558.","DOI":"10.17226\/24624"},{"key":"8514_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.gastro.2023.05.017","volume":"165","author":"P Deepak","year":"2023","unstructured":"Deepak P, Barnes EL, Shaukat A. Health disparities in inflammatory bowel disease care driven by rural versus urban residence: challenges and potential solutions. Gastroenterology 2023;165:11\u201315.","journal-title":"Gastroenterology"},{"key":"8514_CR13","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1097\/MIB.0000000000001133","volume":"23","author":"NZ Borren","year":"2017","unstructured":"Borren NZ, Conway G, Tan W et al. Distance to specialist care and disease outcomes in inflammatory bowel disease. Inflamm Bowel Dis 2017;23:1234\u20131239.","journal-title":"Inflamm Bowel Dis"},{"key":"8514_CR14","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000859724.83110.90","volume":"117","author":"M Craig","year":"2022","unstructured":"Craig M, Ashcroft C, Dulaney D et al. Impact of early biologic therapy in real-world cohort of crohn\u2019s disease patients. Am J Gastroenterol 2022;117:e548.","journal-title":"Am J Gastroenterol"},{"key":"8514_CR15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052501","volume":"149","author":"BD Constant","year":"2022","unstructured":"Constant BD, de Zoeten EF, Stahl MG et al. Delays related to prior authorization in inflammatory bowel disease. Pediatrics 2022;149:e2021052501.","journal-title":"Pediatrics"},{"key":"8514_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.amjcard.2023.09.111","volume":"209","author":"AL Troy","year":"2023","unstructured":"Troy AL, Xu J, Wadhera RK. Access to care and cardiovascular health in us counties with low versus higher-broadband internet availability. Am J Cardiol 2023;209:190\u2013192.","journal-title":"Am J Cardiol"},{"key":"8514_CR17","doi-asserted-by":"publisher","first-page":"215013192311561","DOI":"10.1177\/21501319231156132","volume":"14","author":"N Keene Woods","year":"2023","unstructured":"Keene Woods N, Ali U, Medina M et al. Health literacy, health outcomes and equity: a trend analysis based on a population survey. J Prim Care Community Health 2023;14:21501319231156132.","journal-title":"J Prim Care Community Health"},{"key":"8514_CR18","first-page":"3061","volume":"6","author":"SS Coughlin","year":"2020","unstructured":"Coughlin SS, Vernon M, Hatzigeorgiou C et al. Health literacy, social determinants of health, and disease prevention and control. J Environ Health Sci 2020;6:3061.","journal-title":"J Environ Health Sci"},{"key":"8514_CR19","unstructured":"United States Census Bureau. State and County Literacy Estimates - State Estimates. https:\/\/nces.ed.gov\/naal\/estimates\/stateestimates.aspx."},{"key":"8514_CR20","unstructured":"National Center for Education Statistics. U.S. Census Bureau QuickFacts: Mississippi. https:\/\/www.census.gov\/quickfacts\/fact\/table\/MS\/PST045222."},{"key":"8514_CR21","doi-asserted-by":"publisher","first-page":"S348","DOI":"10.14309\/00000434-201810001-00607","volume":"113","author":"M Delisser","year":"2018","unstructured":"Delisser M, Wei JC, Ramalingam N et al. Variation in IBD prevalence by race\/ethnicity within an integrated healthcare delivery system. Am J Gastroenterol 2018;113:S348.","journal-title":"Am J Gastroenterol"},{"key":"8514_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cgh.2019.06.030","volume":"18","author":"PG Kotze","year":"2020","unstructured":"Kotze PG, Underwood FE, Dami\u00e3o AOMC et al. Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: A systematic review. Clin Gastroenterol Hepatol 2020;18:304\u2013312.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8514_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","volume":"165","author":"JD Lewis","year":"2023","unstructured":"Lewis JD, Parlett LE, Jonsson Funk ML et al. Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States. Gastroenterology 2023;165:1197\u20131205.","journal-title":"Gastroenterology"},{"key":"8514_CR24","unstructured":"FastStats - Health Expenditures. https:\/\/www.cdc.gov\/nchs\/fastats\/health-expenditures.htm."},{"key":"8514_CR25","unstructured":"Filtered Medicaid Enrollment - New Adult Group. https:\/\/data.medicaid.gov\/dataset\/6c114b2c-cb83-559b-832f-4d8b06d6c1b9."},{"key":"8514_CR26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ibd\/izac161","volume":"29","author":"R Greywoode","year":"2023","unstructured":"Greywoode R, Petralia F, Ullman TA et al. Racial difference in efficacy of golimumab in ulcerative colitis. Inflamm Bowel Dis 2023;29:843\u2013849.","journal-title":"Inflamm Bowel Dis"},{"key":"8514_CR27","doi-asserted-by":"publisher","unstructured":"Burstiner LS, Owings AH, Royer A, et al. Black inflammatory bowel disease patients have lower response to antitumor necrosis factor agents compared with white patients. Inflamm Bowel Dis 2023 Feb 21:izad005. https:\/\/doi.org\/10.1093\/IBD\/IZAD005.","DOI":"10.1093\/IBD\/IZAD005"},{"key":"8514_CR28","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1007\/s11605-022-05483-x","volume":"26","author":"AS Ore","year":"2022","unstructured":"Ore AS, Vigna C, Fabrizio A et al. Evaluation of racial\/ethnic disparities in the surgical management of inflammatory bowel disease. J Gastrointest Surg 2022;26:2559\u20132568.","journal-title":"J Gastrointest Surg"},{"key":"8514_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.amjsurg.2023.04.009","volume":"226","author":"BP Smith","year":"2023","unstructured":"Smith BP, Jones BA, Cofer KD et al. Racial disparities in postoperative outcomes persist for patients with inflammatory bowel disease under a colorectal enhanced recovery program. Am J Surg 2023;226:227\u2013232.","journal-title":"Am J Surg"},{"key":"8514_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cgh.2022.05.008","volume":"21","author":"NH Nguyen","year":"2023","unstructured":"Nguyen NH, Luo J, Paul P et al. Effectiveness and safety of biologic therapy in hispanic vs non-hispanic patients with inflammatory bowel diseases: A CA-IBD cohort study. Clin Gastroenterol Hepatol 2023;21:173\u2013181.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8514_CR31","doi-asserted-by":"crossref","first-page":"A127","DOI":"10.1136\/gutjnl-2020-321000","volume":"70","author":"T Townsend","year":"2021","unstructured":"Townsend T, Razanskaite V, Michail S et al. Comparative effectiveness of vedolizumab and ustekinumab in anti-TNF refractory Crohn\u2019s disease: Multi-centre retrospective cohort study. Gut 2021;70:A127.","journal-title":"Gut"},{"key":"8514_CR32","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.14309\/ajg.0000000000001773","volume":"117","author":"S Onali","year":"2022","unstructured":"Onali S, Pugliese D, Caprioli FA et al. An objective comparison of vedolizumab and ustekinumab effectiveness in Crohn\u2019s disease patients\u2019 failure to TNF-alpha Inhibitors. Am J Gastroenterol 2022;117:1279\u20131287.","journal-title":"Am J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08514-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08514-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T17:02:58Z","timestamp":1724432578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08514-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8514"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08514-6","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,4]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.S.C.: Consulting: Abbvie, Adiso, Artizan (SAB), BMS, Clario, Food is Good, Fresenius Kabi, Fzata, Janssen, Pfizer, Prometheus (SAB), ProciseDx, Spherix, Samsung, Protagonist, Takeda; Speaking (non-branded): Abbvie, BMS; K.P.: received lecture\/speaker fees from Physicians Education Resource LLC and Grifols; scientific advisory board fees from ProciseDx Inc and Scipher Medicine Corporation; and consultancy fees from Prometheus Laboratories Inc.; S.C.G serves as a consultant on data monitoring committees for Janssen Research & Development. The remaining authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval was obtained from the Institutional Review Boards of the three participating institutions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}